Selling drugs to the public--should the UK follow the example of the US?
作者信息
Frey John
出版信息
Br J Gen Pract. 2002 Feb;52(475):170-1.
Abstract
摘要
相似文献
1
Selling drugs to the public--should the UK follow the example of the US?
Br J Gen Pract. 2002 Feb;52(475):170-1.
2
Selling drugs to doctors--it's marketing, not education.
Br J Gen Pract. 2002 Feb;52(475):168-9.
3
[Rules of the game in drug marketing].
Duodecim. 1999;115(20):2187, 2189.
4
The role of direct-to-consumer advertising.
Manag Care Interface. 1998 Nov;11(11):79-80, 82.
5
Medical ethics.
Lancet. 2000 Oct 28;356(9240):1522. doi: 10.1016/S0140-6736(05)73270-0.
6
Pharmaceuticals and medical devices: FDA oversight.
Issue Brief Health Policy Track Serv. 2013 Dec 30:1-123.
7
Major issues in marketing regulation.
Food Drug Law J. 1997;52(3):297-302.
8
9
Claim substantiation in the health care industry.
Hosp Mater Manage Q. 1992 May;13(4):20-6.
10
Voluntary self-regulatory codes: what should we expect?
Am J Bioeth. 2003 Summer;3(3):49-50. doi: 10.1162/15265160360706570.
引用本文的文献
1
Selling drugs to doctors--it's marketing, not education.
Br J Gen Pract. 2002 Feb;52(475):168-9.
本文引用的文献
1
Selling drugs to doctors--it's marketing, not education.
Br J Gen Pract. 2002 Feb;52(475):168-9.
2
Lotronex and the FDA: a fatal erosion of integrity.
Lancet. 2001 May 19;357(9268):1544-5. doi: 10.1016/S0140-6736(00)04776-0.
3
Evidence-based advertising? A survey of four major journals.
J Am Board Fam Pract. 2001 May-Jun;14(3):197-200.
4
Do drug company promotions influence physician behavior?
West J Med. 2001 Apr;174(4):232-3. doi: 10.1136/ewjm.174.4.232.
5
Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
Pharmacoeconomics. 2001;19(2):109-19. doi: 10.2165/00019053-200119020-00001.
6
The pharmaceutical industry--to whom is it accountable?
N Engl J Med. 2000 Jun 22;342(25):1902-4. doi: 10.1056/NEJM200006223422509.
7
Reasons for not seeing drug representatives.
BMJ. 1999 Jul 10;319(7202):69-70. doi: 10.1136/bmj.319.7202.69.
8
Trends in antihypertensive drug advertising, 1985-1996.
Circulation. 1999 Apr 20;99(15):2055-7. doi: 10.1161/01.cir.99.15.2055.
9
Regulating pharmaceutical advertising: what will work?
CMAJ. 1997 Feb 1;156(3):359-61.
10
Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.
J Gen Intern Med. 1996 Oct;11(10):640-1. doi: 10.1007/BF02599034.
Zotero 插件